Skip to content

Pharminent

cropped-neurology_aaic_banner_frontpage_2026-07-15-1.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Policy / Pricing
  • US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028
  • Policy / Pricing

US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028

Pharmaceutical Technology

If introduced, the 100% tariffs would apply to all generic drugs imported to the US, which make up 90% of the nation's prescriptions.

Read full story

pharminent July 22, 2026 (Last updated: July 22, 2026)

Pharmaceutical Technology

If introduced, the 100% tariffs would apply to all generic drugs imported to the US, which make up 90% of the nation’s prescriptions.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Novo Nordisk Sues Eli Lilly Over ‘Deceptive’ GLP-1 Advertising
Next: Repligen builds in cell therapy with $1.5bn BioLife takeover

Related Stories

  • Policy / Pricing

UK commits to pharma IP protection in Swiss trade deal

pharminent July 16, 2026
  • Policy / Pricing

Germany approves healthcare costs overhaul despite significant pharma opposition

pharminent July 13, 2026
  • Policy / Pricing

Decoding Medicare Advantage Coding Intensity

pharminent July 1, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.